Association of Inflammatory Biomarkers and Ferritin With Severity of Pediatric Systemic Lupus Erythematosus Patients

Brief summary (registry, in English)

The goal of this observational study is to learn about the association of inflammatory biomarkers (SII, NLR, and PLR) and ferritin with disease severity in pediatric systemic lupus erythematosus (pSLE) patients. The main question it aims to answer is: Are higher levels of SII, NLR, PLR, and ferritin associated with greater disease severity (mild, moderate, severe based on SLEDAI-2K score) in pediatric SLE patients? Participants diagnosed with pediatric SLE will undergo routine blood tests to measure complete blood counts (NLR, PLR, SII) and serum ferritin, and their disease severity will be assessed using the SLEDAI-2K scoring system

What you commit to

• Study type: Observational
• Planned participants: 62
• From 21 Oct 2026 to the primary completion date, 30 Apr 2027
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 11 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov